Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes.

Expert Opin Drug Metab Toxicol · 2016

Last updated 2026-05-28

Journal	Expert Opin Drug Metab Toxicol, 2016
Citations	9
Relative citation ratio	0.23
NIH percentile	15
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction

Full record and abstract on PubMed 27607315 ↗